US Patent 8008281 Methods for the treatment of cancer
Patent 8008281 was granted and assigned to Lankenau Institute for Medical Research on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+114 characters)
Article
Patent abstract
Compositions and methods for the treatment of malignancy and chronic viral infection are disclosed.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alexander J. Muller0
George C. Prendergast0
James B. DuHadaway0
William Malachowski0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008281 Methods for the treatment of cancer US Patent 8008281 Methods for the treatment of cancer
Infobox
Patent Number
080082810
Patent Number
80082810
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080082810
Date of Patent
August 30, 2011
0Patent Application Number
105511510
Date Filed
February 20, 2004
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008281 Methods for the treatment of cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008281
Date of patent
August 30, 2011
Patent application number
10551151
Date Filed
February 20, 2004
Patent primary examiner
Find more entities like US Patent 8008281 Methods for the treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
